Literature DB >> 8472356

Specific glycation of albumin depends on its half-life.

E D Schleicher1, B Olgemöller, E Wiedenmann, K D Gerbitz.   

Abstract

Some suggest that measurements of plasma fructosamine concentration should be corrected for the plasma protein (or albumin) concentration because the extent of glycation per volume depends on both protein and glucose concentrations. Several reports, however, demonstrate a poor correlation between plasma fructosamine and albumin concentrations in diabetic patients. In vitro kinetic and in vivo studies have shown that glycation is also dependent on the half-lives of plasma proteins. Because a decrease in plasma albumin diminishes its catabolism, we speculated that low albumin concentrations are associated with a greater extent of glycation on a molar basis (specific glycation) and vice versa. To test this hypothesis, we studied plasma albumin, total protein, and fructosamine in 63 nondiabetic subjects with normal plasma fasting glucose concentrations and hemoglobin A1c between 5.1% and 5.9%. Plasma fructosamine was poorly correlated with albumin concentration (r = 0.348) but a logarithmic plot of the specific glycation of albumin vs albumin concentration showed a better correlation (r = -0.842), suggesting that the kinetic considerations were operating in vivo. Therefore, because lower specific glycation of plasma albumin "compensates" for higher concentration, correction of fructosamine for albumin content in patients will overestimate mean blood glucose when albumin is low and underestimate it when albumin is high.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8472356

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  19 in total

1.  Effect of glycation of hemoglobin on its interaction with trifluoperazine.

Authors:  Manoj Kar; Anjana Roy; Tania Bose; Abhay Sankar Chakraborti
Journal:  Protein J       Date:  2006-04       Impact factor: 2.371

Review 2.  Managing Diabetes and Cardiovascular Risk in Chronic Kidney Disease Patients.

Authors:  Dragana Lovre; Sulay Shah; Aanu Sihota; Vivian A Fonseca
Journal:  Endocrinol Metab Clin North Am       Date:  2017-12-18       Impact factor: 4.741

3.  An evaluation of serum fructosamine as a marker of the duration of hypoproteinaemic conditions in dogs.

Authors:  S I Thoresen; W P Bredal
Journal:  Vet Res Commun       Date:  1998-04       Impact factor: 2.459

4.  Role of Glycated Proteins in the Diagnosis and Management of Diabetes: Research Gaps and Future Directions.

Authors:  Kerry J Welsh; M Sue Kirkman; David B Sacks
Journal:  Diabetes Care       Date:  2016-08       Impact factor: 19.112

5.  A discrepancy between plasma glycated albumin and HbA1c levels in a patient with steroid-induced diabetes mellitus.

Authors:  Katsumi Iizuka; Takehiro Kato; Masami Mizuno; Jun Takeda
Journal:  BMJ Case Rep       Date:  2016-03-09

Review 6.  Advantages and pitfalls of fructosamine and glycated albumin in the diagnosis and treatment of diabetes.

Authors:  Elisa Danese; Martina Montagnana; Antonio Nouvenne; Giuseppe Lippi
Journal:  J Diabetes Sci Technol       Date:  2015-01-14

7.  The performance of glycated albumin as a biomarker of hyperglycemia and cardiometabolic risk in children and adolescents in the United States.

Authors:  Amelia S Wallace; Mary R Rooney; Tammy M Brady; Justin B Echouffo-Tcheugui; Robert Christenson; Morgan E Grams; Elizabeth Selvin
Journal:  Pediatr Diabetes       Date:  2021-12-26       Impact factor: 4.866

8.  Increased concentration of two different advanced glycation end-products detected by enzyme immunoassays with new monoclonal antibodies in sera of patients with rheumatoid arthritis.

Authors:  Richard Vytásek; Liliana Sedová; Vladimír Vilím
Journal:  BMC Musculoskelet Disord       Date:  2010-05-03       Impact factor: 2.362

9.  Performance of non-traditional hyperglycemia biomarkers by chronic kidney disease status in older adults with diabetes: Results from the Atherosclerosis Risk in Communities Study.

Authors:  Molly Jung; Bethany Warren; Morgan Grams; Yuenting D Kwong; Tariq Shafi; Josef Coresh; Casey M Rebholz; Elizabeth Selvin
Journal:  J Diabetes       Date:  2017-12-21       Impact factor: 4.006

10.  Visceral adiposity is associated with the discrepancy between glycated albumin and HbA1c in type 2 diabetes.

Authors:  Saori Maruo; Koka Motoyama; Tomoe Hirota; Yoshinori Kakutani; Yuko Yamazaki; Tomoaki Morioka; Katsuhito Mori; Shinya Fukumoto; Atsushi Shioi; Tetsuo Shoji; Masaaki Inaba; Masanori Emoto
Journal:  Diabetol Int       Date:  2020-03-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.